INVESTMENT THEME
Cardiovascular Innovators stocks
Amgen looks attractively valued, with progress in cardiovascular drugs in focus, and Q3 earnings could serve as a catalyst for the stock.
Constituents today, average +0.29% · Updated 2026-10-28 22:24 UTC+8
Constituents
| Stock | Price (USD) | Today |
|---|---|---|
| AMGN Amgen | 452.66 | +1.05% |
| LLY Eli Lilly | 1,290.19 | +0.65% |
| MRK Merck | 141.52 | -0.21% |
| PFE Pfizer | 29.67 | -0.44% |
| ARWR Arrowhead | 59.27 | +0.41% |
US-listed shares and ADRs. Tickers link to key levels where we cover the stock.
Latest related news
Amgen: A Biotech Bargain Heading Into Q3 Earnings — SeekingAlpha
Other themes
AI & Robotics +0.48%Solar & Storage -6.43%BoJ Normalization -0.41%Caffeinated Drinks -0.11%Luxury Groups -0.25%P&C Insurance +0.16%Weight-Loss Drugs (GLP-1) +0.04%Rare Earths & Critical Minerals -2.23%Quantum Computing -2.08%Large Language Models -0.39%Autonomous Driving -0.18%AI Medical Imaging +4.70%Gene Editing (CRISPR) +4.02%Streaming Platforms -5.42%Pet Economy +0.20%Small Modular Reactors (SMR) -1.65%Grid & Storage Upgrades -0.27%
Follow this theme in the app
Theme prices, news and constituent charts are in the app, along with one-sentence screening across 8 markets.
Theme constituents are compiled by our research team. For information only; not investment advice or a recommendation.